Blog
RSS FeedPosted by Michael Wonder on 12 Sep 2018
A breakthrough cancer drug has been approved. Now comes the battle over the price.
12 Septemner 2018 - Novartis' breakthrough cancer drug Kymriah has been approved in Europe. Now comes the debate about its ...
Posted by Michael Wonder on 12 Sep 2018
Battle for wonder drug pays off
13 September 2018 - A West Pymble mother feels the “weight of the world” has been lifted following the federal ...
Posted by Michael Wonder on 12 Sep 2018
In Australia, NovaTears eye drops are available on the Pharmaceutical Benefits Scheme
12 September 2018 - Using innovative new technology, NovaTears effectively establishes a new class of treatment for evaporative dry eye. ...
Posted by Michael Wonder on 12 Sep 2018
Decision to list nintedanib (Ofev) and remove restrictions from tiotropium bromide (Spiriva)
12 September 2018 - PHARMAC is pleased to announce a decision to list nintedanib (Ofev) and remove the current Special ...
Posted by Michael Wonder on 11 Sep 2018
ABPI hits out at ‘punitive’ UK medicines cost controls
11 September 2018 - Steep rise in charges an 'alarming signal' amid Brexit uncertainty ...
Posted by Michael Wonder on 11 Sep 2018
Health secretary’s ‘rip off’ remarks anger UK pharma
11 September 2018 - Row with Vertex has tainted government-industry relations. ...
Posted by Michael Wonder on 11 Sep 2018
Scotland could be 'world leader' in precision medicine, says First Minister
9 September 2018 - Scotland has the potential to be a "world leader" in precision medicine, according to the first ...
Posted by Michael Wonder on 11 Sep 2018
Health fund reforms: Parliament passes drastic changes, here is what they mean
11 September 2018 - Health funds will be able to close down your health fund policy and shift you to ...
Posted by Michael Wonder on 10 Sep 2018
NICE turns down Opdivo for adjuvant melanoma therapy
10 September 2018 - BMS drug currently only licensed treatment in this setting. ...
Posted by Michael Wonder on 10 Sep 2018
Canadian Dermatology Association and Canadian Society of Allergy and Clinical Immunology issue joint statement against the Canadian Agency for Drugs and Technologies in health recommendation
10 September 2018 - Many Canadian eczema sufferers are dealt a difficult blow; many patients face a future with no access ...
Posted by Michael Wonder on 10 Sep 2018
SMC - September 2018 decisions
10 September 2018 - The Scottish Medicines Consortium, has today published advice accepting four new medicines for use by NHSScotland. ...
Posted by Michael Wonder on 10 Sep 2018
Drug firms try to rip off taxpayers, says Matt Hancock
8 September 2018 - Pharmaceutical companies are trying to “rip off taxpayers” and big business must be more socially responsible, ...
Posted by Michael Wonder on 10 Sep 2018
Roche faces UK pricing row over multiple sclerosis drug Ocrevus
10 September 2018 - Roche faces a fresh row over drug pricing in Britain, following a decision by the body responsible ...
Posted by Michael Wonder on 10 Sep 2018
MS Society launches petition against NICE’s rejection of Ocrevus
10 september 2018 - The MS Society has launched a petition imploring the National Institute for Health and Care Excellence, ...
Posted by Michael Wonder on 09 Sep 2018
It's not just the EpiPen. Canada had 25 new drug shortages this week alone
8 September 2018 - Migraine and Parkinson's disease drugs and anesthetic among treatments added to drug shortage site. ...